A23V 2250/0644
Taurine
A23V2250/0644 (Taurine) appears on 6 US grants and 11 published applications in this corpus.
Search patents in A23V- Granted patents
- 6
- Published applications
- 11
- Assignees
- 5
- Inventors
- 6
- Latest grant
- 6 Jun 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 2 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 2 |
| 2023 | 2 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Deuterated caffeine and uses thereof6 Jun 2023US 11,666,073 B2Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof10 Jan 2023US 11,547,127 B2Lennham Pharmaceuticals, Inc.
- Method for producing a ready-to-use, long-life infant milk27 Dec 2022US 11,533,942 B2Even Sante Industrie
- Algal and fungal genes and their uses for taurine biosynthesis in cells3 Aug 2021US 11,078,547 B2Plant Sensory Systems, LLC
- Deuterated caffeine and uses thereof8 Sep 2020US 10,765,130 B1Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof7 Aug 2025US 2025/0248424 A1Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof29 Aug 2024US 2024/0284942 A1Lannham Pharmaceuticals, Inc,
- Deuterated caffeine and uses thereof23 Nov 2023US 2023/0371555 A1Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof11 Aug 2022US 2022/0248720 A1Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof21 Jul 2022US 2022/0225642 A1Lennham Pharmaceuticals, Inc.
Most cited
By later US patents
- Deuterated caffeine and uses thereof4US 10,582,716 B1Lennham Pharmaceuticals, Inc. · 2020
- Deuterated caffeine and uses thereof3US 10,765,130 B1Lennham Pharmaceuticals, Inc. · 2020
- Deuterated caffeine and uses thereof1US 11,547,127 B2Lennham Pharmaceuticals, Inc. · 2023
- Deuterated caffeine and uses thereof1US 11,666,073 B2Lennham Pharmaceuticals, Inc. · 2023